NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 746498 | Null | 0.0287337488682932 | 0.64752979 |
NSC 752329 | (Z)-6-(2-(pyridin-2-ylmethylene)hydrazinyl)-9H-purine | 0.0287337488682932 | -0.0005931529 |
NSC 753018 | Null | 0.0287337488682932 | 0.17920301 |
NSC 756133 | GSK1007102B | 0.0287337488682932 | 0.20454276 |
NSC 756193 | GSK978744A | 0.0287337488682932 | 0.37174044 |
NSC 760958 | Null | 0.0287337488682932 | 0.40843896 |
NSC 77007 | Null | 0.0287337488682932 | 0.49335838 |
NSC 93077 | Null | 0.0287337488682932 | 0.19543088 |
NSC 112846 | N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid | 0.0312262198176281 | 0.35067468 |
NSC 128687 | 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) | 0.0312262198176281 | 0.1240524 |